Development
Acrivon Therapeutics, Inc.
ACRV
$1.35
$0.108.00%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.87% | 25.57% | -5.90% | 66.29% | -8.39% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.18% | -37.94% | -13.65% | 134.94% | -43.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.73% | 23.65% | -6.16% | 67.91% | -9.74% |
|
|
|||||
| Total Current Assets | -5.73% | 23.65% | -6.16% | 67.91% | -9.74% |
| Net Property, Plant & Equipment | -2.67% | -3.23% | -4.24% | -3.47% | -1.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.74% | 5.15% | 0.00% | -79.92% | 215.69% |
| Total Assets | -5.60% | -5.96% | -6.09% | 106.61% | -7.67% |
|
|
|||||
| Total Accounts Payable | 18.71% | -7.79% | 51.99% | -54.25% | 3.89% |
| Total Accrued Expenses | 40.46% | 40.05% | -13.90% | 54.97% | 45.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.05% | 1.76% | 1.93% | 1.26% | 1.56% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -27.54% | -- |
| Total Other Current Liabilities | -- | -- | -- | -27.54% | -- |
| Total Current Liabilities | 32.52% | 23.50% | -12.80% | 1.96% | 43.55% |
|
|
|||||
| Total Current Liabilities | 32.52% | 23.50% | -12.80% | 1.96% | 43.55% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.30% | -4.89% | -4.46% | -4.19% | -3.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 19.13% | 11.69% | -9.52% | -0.55% | 19.41% |
|
|
|||||
| Common Stock & APIC | 1.42% | 1.34% | 1.17% | 13,887.78% | 21.90% |
| Retained Earnings | -17.49% | -20.23% | -22.77% | -18.96% | -24.27% |
| Treasury Stock & Other | 29.27% | -4,844.44% | 109.47% | 28.57% | -- |
| Total Common Equity | -7.40% | -7.03% | -5.87% | 473.72% | -24.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
|
|
|||||
| Total Common Equity | -7.40% | -7.03% | -5.87% | 473.72% | -24.72% |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.40% | -7.03% | -5.87% | 121.68% | -10.52% |
|
|
|||||